רספרים

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

SULPHAMETHOXAZOLE; TRIMETHOPRIM

Pieejams no:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ATĶ kods:

J01EE01

Zāļu forma:

תרחיף

Kompozīcija:

SULPHAMETHOXAZOLE 200 MG / 5 ML; TRIMETHOPRIM 40 MG / 5 ML

Ievadīšanas:

פומי

Receptes veids:

מרשם נדרש

Ražojis:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Ārstniecības grupa:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Ārstniecības joma:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Ārstēšanas norādes:

Treatment of urinary tract infections due to susceptible strains of the following organisms: - Escherichia coli - Klebsiella - Enterobacter - Proteus mirabilis - Proteus vulgaris - Proteus morganii. Treatment of acute otitis media in children due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. To date there are limited data available as to the safety of repeated use of Resprim in infants under 2 years of age. Resprim is not indicated for prophylactic or prolonged administration in otitis media at any age. Treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. Treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei. Resprim is also indicated in the treatment of documented Pneumocystis carinii pneumonitis.

Autorizācija datums:

2012-01-31